Biliary cancer
Clinical trials for Biliary cancer explained in plain language.
Never miss a new study
Get alerted when new Biliary cancer trials appear
Sign up with your email to follow new studies for Biliary cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Zapping spreading tumors could extend life on current cancer drugs
Disease control Recruiting nowThis study tests whether adding a targeted, tumor-destroying treatment (like focused radiation or heat ablation) can help people with certain gastrointestinal cancers—such as colorectal, small bowel, or pancreatic cancer—continue their current systemic therapy longer when only a …
Matched conditions: BILIARY CANCER
Sponsor: University of California, Davis • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for bile duct cancer: experimental combo targets tough tumors
Disease control Recruiting nowThis study tests a new drug (CDX-1140) combined with three other cancer drugs for people with advanced biliary tract cancer that has spread or come back after treatment. About 60 adults will receive the drugs through an IV and a pill over 21-day cycles for up to 2 years. The goal…
Matched conditions: BILIARY CANCER
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a routine blood clot test predict Cancer's next move?
Diagnosis Recruiting nowThis study explores whether a common blood test that measures how well blood clots (called TEG) can also act as a biomarker for cancer. Researchers will compare TEG results from patients with several types of cancer (liver, pancreas, bile duct, esophagus, colorectal, and lung) ag…
Matched conditions: BILIARY CANCER
Sponsor: University of Colorado, Denver • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC